Skip Navigation
Search Menu
Find an Expert

 


Peter Anthony Campochiaro, M.D.

Photo of Dr. Peter Anthony Campochiaro, M.D.

Director, Retinal Cell and Molecular Laboratory

Professor of Ophthalmology

Male

Expertise: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Age-Related, Macular Holes, Macular Puckers, Ophthalmology, Proliferative Vitreoretinopathy, Retinal Detachment, Retinal Vessel Occlusion ...read more

Research Interests: Mechanisms involved in ocular neovascularization; Development of new treatments for ocular neovascularization; Mechanisms involved in retinal degenerations; Development of new treatments for retinal degenerations; Ocular Gene Therapy; Clinical trials of ocular neovascularization and macular edema ...read more

Locations

Johns Hopkins Wilmer Eye Institute
Appointment Phone: 410-955-3518

600 N. Wolfe Street
Baltimore, MD 21287 map
Phone: 410-955-3518
Fax: 410-614-7083

Background

Dr. Campochiaro was trained at the University of Notre Dame, Johns Hopkins School of Medicine, the University of Virginia, and Wilmer, joining the Wilmer Faculty in 1991. He is currently the George S. and Dolores Dor Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Institute. His major research interests are in gaining a greater understanding of the roles of peptide growth and trophic factors in the retina and retinal pigmented-epithelium with an ultimate goal of developing new treatments for proliferative retinopathies, choroidal neovascularization and retinal degenerations.

...read more

Titles

  • Director, Retinal Cell and Molecular Laboratory
  • George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience
  • Professor of Ophthalmology
  • Professor of Neuroscience

Centers & Institutes

Education

Degrees

  • MD, Johns Hopkins University School of Medicine (1978)

Residencies

  • University of Virginia Health System / Ophthalmology (1982)

Board Certifications

  • American Board of Ophthalmology / Ophthalmology (1983)

Research & Publications

Lab Website: Retinal Cell and Molecular Laboratory

Clinical Trial Keywords

Diabetic macular edema, Ranibizumab, Central retinal vein occlusion, Branch retinal vein occlusion, Choroidal neovascularization, Gene therapy

Is this you? Edit Profile